DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL

H. D. Folmo; M. M. ter Wee; D. den Uyl; N. P. Konijn; P. J. Kerstens; A. E. Voskuyl; D. van Schaardenburg; M. T. Nurmohamed; M. Boers; W. F. Lems

doi:https://doi.org/10.1136/annrheumdis-2018-eular.5167

DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL

H. D. Folmo, M. M. ter Wee, D. den Uyl, N. P. Konijn, P. J. Kerstens, A. E. Voskuyl, D. van Schaardenburg, M. T. Nurmohamed, M. Boers, W. F. Lems

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	1297-1297
Journal	Annals of the rheumatic diseases
Volume	77
DOIs	https://doi.org/10.1136/annrheumdis-2018-eular.5167
Publication status	Published - Jun 2018

Access to Document

https://doi.org/10.1136/annrheumdis-2018-eular.5167

Cite this

Folmo, H. D., ter Wee, M. M., den Uyl, D., Konijn, N. P., Kerstens, P. J., Voskuyl, A. E., van Schaardenburg, D., Nurmohamed, M. T., Boers, M., & Lems, W. F. (2018). DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL. Annals of the rheumatic diseases, 77, 1297-1297. https://doi.org/10.1136/annrheumdis-2018-eular.5167

@article{b090d8d9d8954713828b2402abdf8256,

title = "DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL",

author = "Folmo, {H. D.} and {ter Wee}, {M. M.} and {den Uyl}, D. and Konijn, {N. P.} and Kerstens, {P. J.} and Voskuyl, {A. E.} and {van Schaardenburg}, D. and Nurmohamed, {M. T.} and M. Boers and Lems, {W. F.}",

year = "2018",

month = jun,

doi = "https://doi.org/10.1136/annrheumdis-2018-eular.5167",

language = "English",

volume = "77",

pages = "1297--1297",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

Folmo, HD, ter Wee, MM, den Uyl, D, Konijn, NP, Kerstens, PJ, Voskuyl, AE , van Schaardenburg, D , Nurmohamed, MT , Boers, M & Lems, WF 2018, 'DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL', Annals of the rheumatic diseases, vol. 77, pp. 1297-1297. https://doi.org/10.1136/annrheumdis-2018-eular.5167

DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL. / Folmo, H. D.; ter Wee, M. M.; den Uyl, D. et al.
In: Annals of the rheumatic diseases, Vol. 77, 06.2018, p. 1297-1297.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL

AU - Folmo, H. D.

AU - ter Wee, M. M.

AU - den Uyl, D.

AU - Konijn, N. P.

AU - Kerstens, P. J.

AU - Voskuyl, A. E.

AU - van Schaardenburg, D.

AU - Nurmohamed, M. T.

AU - Boers, M.

AU - Lems, W. F.

PY - 2018/6

Y1 - 2018/6

U2 - https://doi.org/10.1136/annrheumdis-2018-eular.5167

DO - https://doi.org/10.1136/annrheumdis-2018-eular.5167

M3 - Meeting Abstract

SN - 0003-4967

VL - 77

SP - 1297

EP - 1297

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

ER -

Folmo HD, ter Wee MM, den Uyl D, Konijn NP, Kerstens PJ, Voskuyl AE et al. DECLINE IN ANTI-CCP AND RHEUMATOID FACTOR LEVELS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS AFTER 2 YEARS OF TREATMENT WITH INTENSIVE COMBINATION STRATEGIES, INCLUDING PREDNISOLONE: THE COBRA-LIGHT TRIAL. Annals of the rheumatic diseases. 2018 Jun;77:1297-1297. doi: https://doi.org/10.1136/annrheumdis-2018-eular.5167